Short answer · Medically reviewed summary · Last updated: 2026-04-07
Gillespie syndrome is a rare genetic condition primarily characterized by partial aniridia, non-progressive ataxia, and intellectual disability. While the clinical term Gillespie syndrome is the universally accepted name, it is sometimes referred to as Aniridia-Ataxia Syndrome or Aniridia-Cerebellar Ataxia-Intellectual Disability Syndrome in medical literature. What are the alternative names for Gillespie syndrome? In medical literature and historical records, Gillespie syndrome is rarely referred to by other names, though descriptive terms are often used to define its clinical features.
Gillespie syndrome is a rare genetic condition primarily characterized by partial aniridia, non-progressive ataxia, and intellectual disability. While the clinical term Gillespie syndrome is the universally accepted name, it is sometimes referred to as Aniridia-Ataxia Syndrome or Aniridia-Cerebellar Ataxia-Intellectual Disability Syndrome in medical literature.
In medical literature and historical records, Gillespie syndrome is rarely referred to by other names, though descriptive terms are often used to define its clinical features. You may encounter the following synonyms or descriptive designations: Aniridia-Ataxia Syndrome, Aniridia-Cerebellar Ataxia-Intellectual Disability Syndrome, or simply Gillespie-type Aniridia. These names are descriptive, highlighting the triad of symptoms that define the condition: the absence of part of the iris (aniridia), balance and coordination issues (ataxia), and cognitive delays.
The naming of Gillespie syndrome follows the medical tradition of eponyms, named after the physician Dr. F.D. Gillespie, who first described the condition in 1965. Multiple names exist primarily because early researchers sought to classify the disorder based on its most prominent physical manifestations. As genetic testing has advanced, medical professionals have moved toward using the eponymous name, Gillespie syndrome, to distinguish it from other forms of aniridia caused by different genetic mutations, such as those associated with the PAX6 gene. Standardizing this name helps clinicians and researchers maintain consistency in electronic health records and clinical registries.
For the purposes of clinical documentation, insurance coding, and research, Gillespie syndrome is categorized under specific international identifiers. These codes ensure that patients receive accurate diagnostic tracking across different healthcare systems:
Yes, Gillespie syndrome is the preferred terminology in current clinical practice and international research. While older textbooks or research papers from the 1970s and 80s might use descriptive phrases like "Aniridia-Ataxia," modern genetic counseling and ophthalmological literature use the eponymous name to avoid confusion with other, more common genetic syndromes that feature iris abnormalities. Using the term Gillespie syndrome is the most efficient way to ensure that information shared with your medical team is accurate and up-to-date.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always consult with a qualified healthcare professional regarding any medical condition.